POINT: POINT Biopharma Reports Third Quarter 2023 Financial Results and Provides Business Highlights
POINT Biopharma Global Inc. today announced financial results for the third quarter ended September 30, 2023, and provided a business update.
Read full article »
POINT is an Indiana-based radiopharmaceutical company that develops and commercializes radioligands for the treatment of cancer.
Read more